SCHEMBL82637

SCHEMBL82637

NC(=O)c1ccc[nH]c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.67
TYK2 P29597 1/20 0.58
AURKA O14965 2/20 0.50
DAO P14920 1/20 0.50
AURKB Q96GD4 1/20 0.50
INCENP Q9NQS7 1/20 0.50
PDPK1 O15530 1/20 0.48
PARP1 P09874 1/20 0.46
ALDH1A1 P00352 2/20 0.46
ATM Q13315 1/20 0.46
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SMYD3 Q9H7B4 1/20 0.44
RAB9A P51151 2/20 0.44
GAA P10253 1/20 0.44
CSNK1A1 P48729 1/20 0.43
TYRO3 Q06418 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30935942 0.98 NAPRT (0.64) NAPRTTYK2AURKADAOAURKB
Formic Acid SCHEMBL30227578 0.92 NAPRT (0.58) NAPRTTYK2AURKADAOAURKB
Anthranilamide SCHEMBL5170575 0.89 AURKA (0.55) NAPRTTYK2AURKADAOAURKB
Thiophene SCHEMBL11983176 0.89 NAPRT (0.55) NAPRTTYK2AURKADAOAURKB
SCHEMBL425117 0.82 NAPRT (0.72) NAPRTTYK2AURKADAOAURKB
SCHEMBL8193694 0.82 NAPRT (0.72) NAPRTTYK2AURKADAOAURKB
SCHEMBL5681688 0.81 ALDH1A1 (0.71) NAPRTTYK2AURKAPDPK1PARP1
SCHEMBL1315187 0.81 NAPRT (0.59) NAPRTTYK2AURKADAOAURKB
SCHEMBL5943030 0.81 NAPRT (0.59) NAPRTTYK2AURKADAOAURKB
SCHEMBL440492 0.80 NAPRT (1.00) NAPRTTYK2AURKADAOAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 830 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619407-A1 PYRIDONE AND PYRIMIDINONE INHIBITORS OF HEMATOPOIETIC PROGENITOR KINASE 1 Curadev Pharma Ltd (GB) 2025-09-24 EP claimed
US-20250282794-A1 PYRIDONE AND PYRIMIDINONE INHIBITORS OF HEMATOPOIETIC PROGENITOR KINASE 1 CURADEV PHARMA LTD (GB) 2025-09-11 US claimed
EP-4573085-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2025-06-25 EP claimed
EP-3778608-B1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF JIAXING ANDICON BIOTECH CO LTD (CN) 2025-06-18 EP claimed
CN-119698278-A Small molecule modulators of alveolar type 2 cell proliferation for the treatment of pulmonary diseases 斯克里普斯研究学院 2025-03-25 CN claimed
CN-119546587-A Substituted pyridone compounds as CBL-B inhibitors 格兰玛克制药有限公司 2025-02-28 CN claimed
CN-119403787-A 3- (Sulfonyl or iminosulfonyl) prop-2-en-1-yl ] -2-oxo-1, 2-dihydropyridine-3-carboxamide derivatives 福临德治疗公司 2025-02-07 CN claimed
US-20240293386-A1 NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR LG CHEM, LTD. (KR) 2024-09-05 US claimed
WO-2024105363-A1 PYRIDONE AND PYRIMIDINONE INHIBITORS OF HEMATOPOIETIC PROGENITOR KINASE 1 CURADEV PHARMA LTD (GB) 2024-05-23 WO claimed
EP-3762392-B1 THIENOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME WELLMARKER BIO CO LTD (KR) 2024-05-15 EP claimed
EP-2376080-A1 SYNTHESIS OF CARBAMOYLPYRIDONE HIV INTEGRASE INHIBITORS AND INTERMEDIATES Shionogi&Co., Ltd. (JP) 2011-10-19 EP claimed
CN-101215261-B Method for synthesizing of 2-oxo-3-pyridine formic acid ester and derivatives thereof NANJING UNIVERSITY OF TECHNOLOGY 2011-09-07 CN claimed
WO-2011067184-A1 3- (4, 5 -DIHYDROISOXAZOL- 5 -YL) BENZOYLPYRAZOLE COMPOUNDS AND MIXTURES THEREOF WITH SAFENERS BASF SE (DE) 2011-06-09 WO claimed
WO-2010068253-A1 SYNTHESIS OF CARBAMOYLPYRIDONE HIV INTEGRASE INHIBITORS AND INTERMEDIATES SHIONOGI & CO., LTD. (JP) 2010-06-17 WO claimed
CN-101215261-A Method for synthesizing of 2-oxo-3-pyridine formic acid ester and derivatives thereof NANJING UNIVERSITY OF TECHNOLOGY (CN) 2008-07-09 CN claimed
US-20060135589-A1 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors ASTEX TECHNOLOGY, INC. (GB) 2006-06-22 US claimed
JP-2006500348-A 2006-01-05 JP claimed
EP-1534685-A1 1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS CYCLIN DEPENDENT KINASES (CDK) INHIBITORS Astex Technology Limited (GB) 2005-06-01 EP claimed
WO-2004014864-A1 1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS CYCLIN DEPENDENT KINASES (CDK) INHIBITORS ASTEX TECHNOLOGY LIMITED (GB) 2004-02-19 WO claimed
WO-2001077078-A1 NOVEL PYRIDONES AND THEIR USE AS MODULATORS OF SERINE HYDROLASE ENZYMES DALHOUSIE UNIVERSITY (CA) 2001-10-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282794-A1 PYRIDONE AND PYRIMIDINONE INHIBITORS OF HEMATOPOIETIC PROGENITOR KINASE 1 PDXK, PGK1, CMPK1 NAPRT 892/4885TYK2 227/4885AURKA 418/4885
US-20060135589-A1 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors CCNC, CDK1, CDK7 NAPRT 283/4885TYK2 66/4885AURKA 659/4885
US-20240293386-A1 NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR MAP3K20, SBK3, MAPKAPK2 NAPRT 1807/4885TYK2 646/4885AURKA 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.